Coronavirus (COVID-19) Update: October 19, 2021
Coronavirus (COVID-19) Update: October 19, 2021
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-october-19-2021
Coronavirus (COVID-19) Update: October 19, 2021
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-october-19-2021
FDA Permits Marketing of New Oral Tobacco Products through Premarket Tobacco Product Application Pathway
http://www.fda.gov/news-events/press-announcements/fda-permits-marketing-new-oral-tobacco-products-through-premarket-tobacco-product-application
FDA Issues Landmark Proposal to Improve Access to Hearing Aid Technology for Millions of Americans
http://www.fda.gov/news-events/press-announcements/fda-issues-landmark-proposal-improve-access-hearing-aid-technology-millions-americans
Unauthorized injectable drugs and medical devices seized from Vivian Spa in Mississauga, ON, may pose serious health risks
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76677a-eng.php
427 mujeres fallecieron en el 2020 producto del cáncer de mama
18 de octubre del 2021. Según datos de la Dirección de Vigilancia de la Salud del Ministerio de Salud, en Costa Rica para el año 2020...
FDA Approves Cyltezo, the First Interchangeable Biosimilar to Humira
http://www.fda.gov/news-events/press-announcements/fda-approves-cyltezo-first-interchangeable-biosimilar-humira
Solución salina (ClNa 0. 9%) para la inyección de medios de contraste en tomografía computarizada o resonancia magnética en pacientes con cáncer de mama, cuello uterino y estómago
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1337715
Inhibidores multiquinasas en el tratamiento de cáncer diferenciado de tiroides refractario a tratamiento con yodo radioactivo
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1337728